跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
none - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
none
Approved
STANDARD
none
Cipla Limited (Unit I)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
705024449fdf02c6
Company
Cipla Limited (Unit I)
Type
Standard
Approval Details
Approval Id
705024449fdf02c6
Drug Approval Philippines Name
none
Product Name
none
Registration Number
DRP-14860
Brand Name
none
Generic Name
Salbutamol (as sulfate) + Ipratropium bromide.
Dosage Form
Solution for Nebulization
Dosage Strength
2.5 mg/ 500 mcg per 2.5 mL
Manufacturer
Cipla Limited (Unit I)
Importer
SMHP Pharmaceuticals Incorporated.
Distributor
SMHP Pharmaceuticals Incorporated.
Issuance Date
25 January 2024
Expiry Date
25 January 2029
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
705024449fdf02c6
Type
Standard
Back to Philippines FDA Approvals